Women's feedback on a chemopreventive trial for cervical dysplasia.
This study identifies the risks, benefits, and social influences affecting the decision to participate in a chemoprevention trial for cervical dysplasia. Women from three clinical sites in southeastern Michigan were invited to participate in a semi-structured interview. In previous studies, minority women have significant barriers to participation in clinical trials. However, in this study, women (63% black, 26% white, and 9% other ethnicity), were interested in participating and reported only moderate barriers. These barriers could easily be addressed with resources available to investigators.
Bieniasz
Mary E
ME
Department of Family Medicine, University of Michigan, 1018 Fuller Street, Ann Arbor, MI 48109-0708, USA.
Underwood
Diana
D
Bailey
Joanne
J
Ruffin
Mack T
MT
D000328:Adult; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003657:Decision Making; D005006:Ethnicity; D005246:Feedback; D005260:Female; D006801:Humans; D008824:Michigan; D018579:Patient Selection; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control*
D016588:Anticarcinogenic Agents